| 000 | 01865 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250514225420.0 | ||
| 264 | 0 | _c20060106 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/01.WNL.0000160401.24880.83 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonneville, F | |
| 245 | 0 | 0 |
_aParkinson disease, brain volumes, and subthalamic nucleus stimulation. _h[electronic resource] |
| 260 |
_bNeurology _cMay 2005 |
||
| 300 |
_a1598-604 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aActivities of Daily Living |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAtrophy _xetiology |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aBrain Mapping _xmethods |
| 650 | 0 | 4 |
_aDeep Brain Stimulation _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease _xpathology |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 |
_aSubthalamic Nucleus _xphysiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWelter, M L | |
| 700 | 1 | _aElie, C | |
| 700 | 1 | _adu Montcel, S Tezenas | |
| 700 | 1 | _aHasboun, D | |
| 700 | 1 | _aMenuel, C | |
| 700 | 1 | _aHoueto, J L | |
| 700 | 1 | _aBonnet, A M | |
| 700 | 1 | _aMesnage, V | |
| 700 | 1 | _aPidoux, B | |
| 700 | 1 | _aNavarro, S | |
| 700 | 1 | _aCornu, P | |
| 700 | 1 | _aAgid, Y | |
| 700 | 1 | _aDormont, D | |
| 773 | 0 |
_tNeurology _gvol. 64 _gno. 9 _gp. 1598-604 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.WNL.0000160401.24880.83 _zAvailable from publisher's website |
| 999 |
_c15546427 _d15546427 |
||